Hanan Darwish
(email)
5. FOLFIRINOX in Advanced Pancreatic Cancer, NEMROCK Experience
View
What links here
Citation:
El Ghonemy E, S. H*, Sakr A, and S. H., 5. FOLFIRINOX in Advanced Pancreatic Cancer, NEMROCK Experience, , 2014.
Export
RTF
Tagged
XML
BibTex
Google Scholar
Type of Work:
original article
Preview
Attachment
Size
cor2-17002058_1.pdf
219 KB
Publications
Bio
Classes
Calendar
Arab Journal of nuclear sciences and application ; 46(4),312-321,2013
International Journal of Cancer Management and Research 2013:5, 7 October
International Journal of Cancer and Oncology Research 2(3): 35-41, 2014
Kasr El-Aini J. Clin. Oncol. Nucl. Med. Vol.6, No.3-4, Jul. - Oct. 2010:39-46
Ů„poster in ESMO,OCT,2016
Recent Publications
6. Effect of protracted radiotherapy treatment on outcome of head and neck cancer patients.
5. FOLFIRINOX in Advanced Pancreatic Cancer, NEMROCK Experience
Change in survival in locally advanced laryngeal carcinoma patients over past three decade.
4. Prospective study evaluating the radiosensitizing effect of reduced doses of temozolomide in the treatment of Egyptian patients with glioblastoma multiforme
2. Ependymoma: prognostic factors and survival, single institution experience (NEMROCK).
more
